Risk of breast cancer associated with short-term use of oral contraceptives

Cancer Causes and Control

Volumn 18, Issue 2, 2007, Pages 189-198

  Folger, Suzanne G ^a,b   Marchbanks, Polly A ^a   McDonald, Jill A ^a   Bernstein, Leslie ^c   Ursin, Giske ^c,d   Berlin, Jesse A ^e   Daling, Janet R ^f   Norman, Sandra A ^g   Strom, Brian L ^g   Weiss, Linda K ^h   Simon, Michael S ⁱ   Burkman, Ronald T ^j   Malone, Kathleen E ^f   Spirtas, Robert ^k  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Mailstop K34 ^*  (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^f USA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

^j BAYSTATE MEDICAL CENTER   (United States)

^k EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

Breast cancer; Case control studies; Epidemiology; Oral contraceptives

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENSTRUATION; NEGRO; ORAL CONTRACEPTION; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; RISK REDUCTION; SHORT COURSE THERAPY;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; RISK; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 33846818410     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-006-0086-7     Document Type: Article

References (26)

1. Wingo PA, Lee NC, Ory HW, Beral V, Peterson HB, Rhodes P (1991) Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obstet Gynecol 78:161-170
2. Lipworth L, Katsouyanni K, Stuver S, Samoli E, Hankinson SE, Trichopoulos D (1995) Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece. Int J Cancer 62:548-551
3. Chie W-C, Li C-Y, Huang C-S, Chang K-J, Yen M-L, Lin R-S (1998) Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int J Cancer 77:219-223
4. LaVecchia C, Negri E, Franceschi S et al (1995) Oral contraceptives and breast cancer: a cooperative Italian study. Int J Cancer 60:163-167
5. Kumle M, Weiderpass E, Braaten T, Persson I, Adami H-O, Lund E (2002) Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish women's lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev 11:1375-1381
6. Gross TP, Schlesselman JJ, Stadel BV, Yu W, Lee NC (1992) The risk of ovarian cancer in short-term users of oral contraceptives. Am J Epidemiol 136:46-53
7. Greer JB, Modugno F, Allen GO, Ness RB (2005) Short-term oral contraceptive use and the risk of epithelial ovarian cancer. Am J Epidemiol 162:66-72
8. Hatcher RA, Guillebaud J (1998) The pill: combined oral contraceptives. In: Hatcher RA, Trussell J, Stewart F (eds) Contraceptive Technology, 17th ed. Ardent Media, New-York, pp 405-466
9. Rosenburg MJ, Waugh MA (1998) Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179:577-582
10. Marchbanks PA, McDonald JA, Wilson HG et al (2002) The NICHD women's contraceptive and reproductive experiences study: methods and operational results. Ann Epidemiol 12:213-221
11. Marchbanks PA, McDonald JA, Wilson HG et al (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med 346:2025-2032
12. Hatcher RA, Guest F, Stewart F et al. (1989) Combined oral contraceptives. In: Breedlove RA, Judy B, Martin N (eds) Contraceptive Technology 1988-1989, 14 ed. Irvington Publishers, Inc., New York, pp 202-203
13. Olsson H, Moller TR, Ranstam J (1989) Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. J Natl Cancer Inst 81:1000-1004
14. Romieu I, Berlin JA, Colditz G (1990) Oral contraceptives and breast cancer. Review and meta-analysis. Cancer 66:2253-2263
15. McPherson K, Neil A, Vessey MP, Doll R (1983) Oral contraceptives and breast cancer. Lancet 2:1414-1415
16. Brinton LA, Daling JR, Liff JM et al (1995) Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 87:827-835
17. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraception: further results. Contraception 54(Suppl):1S-106S
18. Jernstrom H, Loman N, Johannsson OT, Borg A, Olsson H (2005) Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer 41:2312-2320
19. The ESHRE Capri Workshop Group (2005) Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update 11:513-525
20. Junod SW, Marks L (2002) Women's trials: the approval of the first oral contraceptive pill in the United States and Great Britain. J Hist Med Allied Sci 57:117-160
21. Jensen JT, Speroff L (2000) Health benefits of oral contraceptives. Obstet Gynecol Clin North Am 27:705-721
22. Chiaffarino F, Parazzini F, La Vecchia C, Ricci E, Crosignani PG (1998) Oral contraceptive use and benign gynecologic conditions. Contraception 57:11-18
23. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699-1703
24. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176:572-579
25. Ness RB, Modugno F (2006) Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers. Eur J Cancer 42:691-703
26. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713-1727